The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -81.46%.However, over the last six months, we can see a stronger performance of -79.15%. Over the last 30 days, the price of BDSX has leaped by -36.71%. And in the last five days, it has fallen by -12.87%.
Biodesix Inc’s market performance has been unstable in recent times.
52-week price history of BDSX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Biodesix Inc’s current trading price is -86.10% away from its 52-week high, while its distance from the 52-week low is 65.08%. The stock’s price range during this period has varied between$0.17 and $2.04. The Biodesix Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.14 million for the day, a figure considerably lower than their average daily volume of 8.2 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Biodesix Inc (BDSX) has experienced a quarterly decline of -66.64% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 41.56M and boasts a workforce of 273 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
BDSX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BDSX stands at 5.63. Similarly, the long-term debt-to-equity ratio is also 5.53.
